Predicting the impact of non-pharmaceutical interventions against COVID-19 on Mycoplasma pneumoniae in the United States

Sang Woo Park, Brooklyn Noble, Emily Howerton, Bjarke F. Nielsen, Sarah Lentz, Lilliam Ambroggio, Samuel Dominguez, Kevin Messacar, Bryan T. Grenfell

Research output: Contribution to journalArticlepeer-review

Abstract

The introduction of non-pharmaceutical interventions (NPIs) against COVID-19 disrupted circulation of many respiratory pathogens and eventually caused large, delayed outbreaks, owing to the build up of the susceptible pool during the intervention period. In contrast to other common respiratory pathogens that re-emerged soon after the NPIs were lifted, longer delays (> 3 years) in the outbreaks of Mycoplasma pneumoniae (Mp), a bacterium commonly responsible for respiratory infections and pneumonia, have been reported in Europe and Asia. As Mp cases are continuing to increase in the US, predicting the size of an imminent outbreak is timely for public health agencies and decision makers. Here, we use simple mathematical models to provide robust predictions about a large Mp outbreak ongoing in the US. Our model further illustrates that NPIs and waning immunity are important factors in driving long delays in epidemic resurgence.

Original languageEnglish (US)
Article number100808
JournalEpidemics
Volume49
DOIs
StatePublished - Dec 2024

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Parasitology
  • Microbiology
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases
  • Virology

Keywords

  • Bayesian inference
  • Mathematical model
  • Mycoplasma pneumoniae
  • Non-pharmaceutical interventions
  • Outbreak prediction

Fingerprint

Dive into the research topics of 'Predicting the impact of non-pharmaceutical interventions against COVID-19 on Mycoplasma pneumoniae in the United States'. Together they form a unique fingerprint.

Cite this